rn: la déception des militants
Published 2 weeks ago • 72K plays • Length 3:46Download video MP4
Download video MP3
Similar videos
-
1:21
overview of the role of non-covalent btk inhibitors in the era of covalent btk inhibitors
-
1:51
how to manage tumor flare after administration of bispecific antibodies
-
3:41
teclistamab: bcma x cd3 bispecific antibody in rrmm
-
1:55
the real-world efficacy of brentuximab vedotin consolidation post-autosct in r/r hl
-
5:28
regn5459, a bcma×cd3 bispecific antibody, in r/r multiple myeloma
-
1:04:53
panel 3 — what is normal and what is pathological? (with closing remarks)
-
2:16
dr. larner on integrating radiation therapy with immune checkpoint blockade in nsclc
-
56:53
rli/imaging 3.0 webinar series: "the network effect"
-
1:59
tangible benefit for flt3-itd r/r aml on quizartinib
-
3:18
nurse-led research: the vccc hub
-
0:23
you've been heard. #5
-
1:30
save contrast, radiation, time with 3d roadmap technology
-
2:53
d-bx powering the mission (external)
-
1:33
rcn clinical leadership programme 2010 - abm university health board
-
1:16
3d modality fusion improves workflow and limits radiation/contrast
-
59:38
rsm covid-19 series | episode 105: the bivalent vaccine
-
7:35
data supporting quizartinib in flt3 r/r aml
-
1:03
kb 001793 | time-dependent analysis add-on in rfem 6 and rstab 9
-
1:44
celide flemington, rdcs/rvt